COVISHIELD: Enrollment of phase 3 clinical trials completed by ICMR
and SII ICMR and Serum Institute of India (SII), Pune, has declared
that, as of 31 October 2020, the enrolment procedure of phase 3
clinical trials for COVISHIELD has been concluded. This vaccine was
originally developed by Oxford University/Astra Zeneca trial. It is
also under […]
The post ICMR & Serum Institute Of India Completes Phase 3 Clinical
Trials Of COVISHIELD appeared first on BioTecNika .
https://www.biotecnika.org/2020/11/covishield-enrollment-of-clinical-trials-completed-phase-3/
Biotech News
No comments:
Post a Comment